Natco Pharma Grows 0.09% as Peers Shift: Market Insights & Valuation Snapshot
Natco Pharma’s stock barely edges higher amid a month‑long dip, trading near ₹792 with a 200‑day SMA below ₹934; investors compare its volatility to peers in energy, metals and healthcare.
3 minutes to read

